Share

Networks

Clinical Studies (5)

  • FLUVAC EV-03 : Study aims to estimate influenza and pneumococcal vaccination coverage among adults hospitalised with severe acute respiratory infections and analyse factors associated with vaccination
  • Aguilaniu : Study aims to conduct a large descriptive analysis of cardiopulmonary exercise testing to improve the understanding of persistent symptoms and in particular the diversity of physiological response presentations in post acut SARS-CoV-2 infection patients
  • DisCOVID : Study aims to provide a deep understanding of non-fatal health outcomes in people surviving COVID-19, by comprehensively and systematically mapping and monitoring, within the WHO International Classification of Functioning, Disability and Health framework, disability levels and profiles, in the mid and long terms in people surviving COVID-19
  • CoCoPrev : Study aims to assess the impact of monoclonal antibodies and direct antiviral therapies on clinical and virological outcomes in high-risk patients with early mild-to-moderate COVID-19, including sequencing to identify viral population changes and emerging minority variants.
  • Nguyen : Study aims to describe the incidence and outcomes of COVID-19 among immunocompromised patients receiving tixagevimab/cilgavimab as preexposure prophylaxis during the Omicron wave in France

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Influenza virus
  • Streptococcus pneumoniae
  • Post COVID-19 condition
  • Acute COVID-19
  • Influenza
  • Streptococcus pneumoniae infection
  • Pharmacological intervention
  • Monoclonal antibodies
  • Vaccination
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to